ProQR Therapeutics NV (NASDAQ: PRQR) is a Dutch biotechnology company based in Leiden, the Netherlands, with a presence in Cambridge, Massachusetts, US. The company was funded in 2012 by chief executive officer (CEO) Daniel A. de Boer. It specializes in the development of RNA therapeutics using its RNA editing platform technology called Axiomer.
ProQR Therapeutics - Creating RNA therapies for patients in need
ProQR is a biotech company that discovers and develops unique RNA therapies for severe rare and common diseases, based in Leiden, The Netherlands.
proqr.com →Link to the official site · 7,540 chars · not written by Vinony
via Wikidata · CC0
~8 min read
To offer you the best possible service, this site uses functional cookies as well as cookies for web statistics and videos. By clicking "Allow cookies" or continuing to use this website you give us consent to use cookies.
Allow cookies
Discovered by embedding cosine similarity (sentence-transformers MiniLM, 384-dim).